EBR Systems to Meet with US FDA for Cardiac Pacing Device Application; Shares Up 5%

MT Newswires Live

Dec 06, 2024

EBR Systems (ASX:EBR) will meet with the US Food and Drug Administration on Dec. 20 to discuss the pre-market approval application for its wireless cardiac pacing device using its WiSE CRT system, according to a Friday filing with the Australian bourse.

The so-called Day-100 meeting will allow both parties to discuss the status of the company's application and see if the regulator needs any additional requirements to advance the review, the filing said.

The meeting was made possible via the device's breakthrough device designation, which allows interactive communication during the evaluation process, the filing added.

The company's shares jumped nearly 5% in recent Friday trade.

Price (AUD): $0.93, Change: $+0.04, Percent Change: +4.85%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2489840449"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2489840449\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2489840449?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-06 08:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2489840449","market":"sh","top_or_hot":-1,"title":"EBR Systems to Meet with US FDA for Cardiac Pacing Device Application; Shares Up 5%","media":"MT Newswires Live","content":"<html><body><p> EBR Systems (ASX:EBR) will meet with the US Food and Drug Administration on Dec. 20 to discuss the pre-market approval application for its wireless cardiac pacing device using its WiSE CRT system, according to a Friday filing with the Australian bourse.</p><p>The so-called Day-100 meeting will allow both parties to discuss the status of the company's application and see if the regulator needs any additional requirements to advance the review, the filing said.</p><p>The meeting was made possible via the device's breakthrough device designation, which allows interactive communication during the evaluation process, the filing added.</p><p>The company's shares jumped nearly 5% in recent Friday trade.</p><p>Price (AUD): $0.93, Change: $+0.04, Percent Change: +4.85%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EBR Systems to Meet with US FDA for Cardiac Pacing Device Application; Shares Up 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEBR Systems to Meet with US FDA for Cardiac Pacing Device Application; Shares Up 5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-12-06 08:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> EBR Systems (ASX:EBR) will meet with the US Food and Drug Administration on Dec. 20 to discuss the pre-market approval application for its wireless cardiac pacing device using its WiSE CRT system, according to a Friday filing with the Australian bourse.</p><p>The so-called Day-100 meeting will allow both parties to discuss the status of the company's application and see if the regulator needs any additional requirements to advance the review, the filing said.</p><p>The meeting was made possible via the device's breakthrough device designation, which allows interactive communication during the evaluation process, the filing added.</p><p>The company's shares jumped nearly 5% in recent Friday trade.</p><p>Price (AUD): $0.93, Change: $+0.04, Percent Change: +4.85%</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EBR.AU","symbol_name":"EBR SYSTEMS INC-CDI","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2489840449","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2489840449","pubTimestamp":1733444805,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"EBR Systems  will meet with the US Food and Drug Administration on Dec. 20 to discuss the pre-market approval application for its wireless cardiac pacing device using its WiSE CRT system, according to a Friday filing with the Australian bourse.The so-called Day-100 meeting will allow both parties to discuss the status of the company's application and see if the regulator needs any additional requirements to advance the review, the filing said.The meeting was made possible via the device's breakthrough device designation, which allows interactive communication during the evaluation process, the filing added.The company's shares jumped nearly 5% in recent Friday trade.Price : $0.93, Change: $+0.04, Percent Change: +4.85%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EBR.AU":"EBR SYSTEMS INC-CDI","LU0426417589.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) INC","BK4125":"广播","BK4081":"电力公用事业","LU1043141123.HKD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (HKD) INC 2","LU0345774631.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) INC","LU2238339852.HKD":"NINETY ONE GSF GLOBAL ENVIRONMENT \"A\" (HKD) ACC","LU0994945656.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) INC 2","BK7007":"医疗保健设备","LU0426412945.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) ACC","IE00B1B80R65.USD":"柏瑞拉丁美洲股票A"},"translate_title":"EBR Systems将与美国FDA会面，讨论心脏起搏装置的应用；股价上涨5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EBR":1,"EBR.AU":0.9,"AUD":1},"content_text":"EBR Systems (ASX:EBR) will meet with the US Food and Drug Administration on Dec. 20 to discuss the pre-market approval application for its wireless cardiac pacing device using its WiSE CRT system, according to a Friday filing with the Australian bourse.The so-called Day-100 meeting will allow both parties to discuss the status of the company's application and see if the regulator needs any additional requirements to advance the review, the filing said.The meeting was made possible via the device's breakthrough device designation, which allows interactive communication during the evaluation process, the filing added.The company's shares jumped nearly 5% in recent Friday trade.Price (AUD): $0.93, Change: $+0.04, Percent Change: +4.85%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}